Celltrion Inc.
Scope
Date
~
-
Corporate bonds
Korean firms at risk of credit rating downgrade on Legoland woes
South Korean companies are at risk of credit rating downgrades as the fallout of a debt default by the domestic developer of a Legoland theme park r...
Nov 13, 2022 (Gmt+09:00)
-
Earnings
Celltrion's Q3 earnings boosted by Remsima sales in Europe
South Korean biopharmaceutical giant Celltrion Inc. announced 654.6 billion won ($478.2 million) in revenue and 213.8 billion won in operating profi...
Nov 09, 2022 (Gmt+09:00)
-
Corporate strategy
Korea Inc. accumulates cash as economic downturn deepens
South Korean companies, led by the country’s most valuable firm Samsung Electronics Co., have rushed to accumulate cash as interest rates kept...
Nov 07, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Foreign PE firms on hunt for Korea Inc. with strong dollar
Foreign private equity firms have taken advantage of the strong dollar to dominate corporate acquisition deals in South Korea, adding to expectation...
Nov 01, 2022 (Gmt+09:00)
-
Korean stock market
Rising interest rates reshuffle Korean market cap list
Rising interest rates amid a slowing global economy rattled South Korean companies’ market capitalization rankings, bumping online players suc...
Oct 28, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Firm dollar deters Korea Inc.’s overseas acquisition deals
The firm dollar is causing South Korean companies to postpone or cancel their plans to buy overseas firms for future growth as the US currency&rsquo...
Oct 13, 2022 (Gmt+09:00)
-
Healthcare
Celltrion targets digital healthcare sector with app
Celltrion Inc., South Korea’s biopharmaceutical giant, made a foray into the digital healthcare sector for its future growth by launching a sm...
Oct 05, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins sales approval for biosimilar Vegzelma in Japan
Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...
Sep 27, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion gains sales approval for biosimilar Vegzelma in Europe
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...
Aug 19, 2022 (Gmt+09:00)
-
Corporate investment
Korea Inc. cuts factory runs, capex on record inventory
Samsung Electronics Co. and other major South Korean companies have reduced their plant operations and capital expenditures as weakening demand amid...
Aug 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare logs record-high Q2 revenue on back of Remsima
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.’s global marketing affiliate, posted its record-high second-quar...
Aug 17, 2022 (Gmt+09:00)
-
Corporate restructuring
Korea Inc. rushes to cut debt as interest rates surge
South Korean companies scrambled for lowering debts and borrowing costs with new financial and business strategies as interest rates on corporate lo...
Aug 10, 2022 (Gmt+09:00)
-
Earnings
Celltrion logs strong Q2 earnings powered by biosimilars
South Korea’s biopharmaceutical maker Celltrion Inc. on Friday reported strong quarterly earnings thanks to healthy demand for its biosimilar ...
Aug 05, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Samsung Biologics eye record-high annual sales
South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...
Jul 08, 2022 (Gmt+09:00)
-
Economy
Korea Inc. hit by rising commodity prices, weak won, supply crisis
South Korea’s major industries, especially the petrochemical and auto parts sectors, are suffering from surging global commodity prices, a wea...
Jun 15, 2022 (Gmt+09:00)
language -
Carbon neutrality
SK ties up with Bill Gates’ TerraPower for small nuclear reactor biz
SK Group, South Korea’s No. 2 conglomerate, joined hands with TerraPower, an advanced nuclear power venture founded by billionaire Bill Gates,...
May 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion to sell biosimilar products via its own channel in Europe
South Korea's biopharmaceutical company Celltrion Inc. plans to sell all of its biosimilar products through its own sales channels in Europe to impr...
May 11, 2022 (Gmt+09:00)
-
Electric vehicles
SK buys power semiconductor maker for EV chip business
SK Group, South Korea’s third-largest conglomerate, has geared up its electric vehicle chip business development with the acquisition of a loc...
Apr 27, 2022 (Gmt+09:00)
-
Artificial intelligence
CJ integrates AI infrastructure and data to launch CJ AI center
CJ Corp. launched an artificial intelligence center Wednesday, which it hopes will lead the conglomerate's digital innovation. The new CJ AI Cente...
Apr 21, 2022 (Gmt+09:00)
-
Shareholder activism
US hedge fund urges SK to focus on share buybacks
US hedge fund Dalton Investments LLC has urged SK Inc., the holding company of South Korea’s SK Group, to focus more on share buybacks and can...
Apr 08, 2022 (Gmt+09:00)
-
War in Ukraine
Korea Inc. in dilemma over Russia biz amid Ukraine war
South Korea’s major companies are in a sticky situation over their businesses in Russia following its invasion of Ukraine. Governments in the ...
Mar 08, 2022 (Gmt+09:00)
language -
War in Ukraine
Perfect storm from Ukraine crisis clouds Korea Inc.’s outlook
South Korean companies had dreamed of a post-COVID-19 earnings recovery as the globe geared up for economic reopening. But their hopes are now dampe...
Feb 25, 2022 (Gmt+09:00)
language -
Economy
Korea Inc. revises business plans as rising oil prices hit economy
South Korean companies are revising their business plans for this year as soaring oil prices slam Asia’s fourth-largest economy. Inflation is ...
Feb 21, 2022 (Gmt+09:00)
language -
Pharmaceuticals
Celltrion, Humasis to ship $300 mn COVID-19 test kits to US
South Korea's biopharmaceutical company Celltrion Inc. and diagnostic kit manufacturer Humasis Co. have signed contracts to supply their jointly-dev...
Feb 04, 2022 (Gmt+09:00)
-
Korean stock market
EcoPro BM beats Kosdaq's top market cap Celltrion
EcoPro BM Co., a leading manufacturer of cathode material for secondary batteries, topped the market capitalization for Kosdaq-listed firms on Jan...
Jan 19, 2022 (Gmt+09:00)
language -
Shareholder value
Tighter rules on business split-ups may benefit SK Inc.
As South Korean securities regulators are moving to tighten their grip on the growing trend of splitting up businesses and listing the spun-off arms...
Jan 11, 2022 (Gmt+09:00)
-
CES 2022
Convergence, metaverse, green: Korea Inc.’s themes at CES 2022
South Korea’s major companies are showcasing robots, mobility and the metaverse rather than cutting-edge models of their conventional products...
Jan 04, 2022 (Gmt+09:00)
-
Artificial intelligence
Ex-quant developer on a mission to save traders' microseconds
A Korean startup about a year old has succeeded in creating a microchip that speeds up trading by a few microseconds -- a huge difference in the w...
Dec 06, 2021 (Gmt+09:00)
language -
Pharamaceuticals, biotech
Celltrion to conduct tests on Omicron variant detected in Korea
Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...
Dec 06, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
Korea Inc 2021: Year of record M&As, tie-ups and spin-offs
South Korea’s corporate sector has seen record deals through mergers and acquisitions, tie-ups and spin-offs this year, as big companies and s...
Dec 03, 2021 (Gmt+09:00)